Windy City Media Group Frontpage News

THE VOICE OF CHICAGO'S GAY, LESBIAN, BI, TRANS AND QUEER COMMUNITY SINCE 1985

home search facebook twitter join
Gay News Sponsor Windy City Times 2022-08-31
DOWNLOAD ISSUE
Donate

Sponsor
Sponsor

  WINDY CITY TIMES

HIV drugs can prevent infection
by Bob Roehr
2010-12-01

This article shared 3904 times since Wed Dec 1, 2010
facebook twitter google +1 reddit email


HIV drugs can do a remarkable job of suppressing high viral loads to undetectable levels, but can they prevent that infection in the first place? Most people thought that they could in theory but there was no proof of that … until now.

Results from the Preexposure Prophylaxis Initiative ( iPrEx ) Trial found that drugs could reduce new infections by 43.8 percent in the high-risk men who have sex with men ( MSM ) and transgender persons in the study. It was published in the New England Journal of Medicine Nov. 23.

The $43.6-million trial enrolled 2,499 participants at 11 sites on four continents, including San Francisco and Boston in the United States. Despite the fact that MSM are much more likely to be infected with HIV—they are more than half of those infected in the US and in the broader epidemic of sub-Saharan Africa they are at least four times as likely as their heterosexual counterparts to be infected with the virus—this is the first large biochemical prevention study conducted in MSM.

Participants were randomized to receive once a day dose of either Truvada, a single pill containing the drugs emtricitabine and tenofovir, or placebo, essentially a sugar pill with no active ingredients. They also received counseling on HIV prevention at every meeting with the study team. The analysis was based on a median of 1.2 years on the drug.

Of the first 100 people to become infected with HIV, 64 were receiving placebo ( an annual infection rate of about 4 percent ) and 36 were on Truvada. The 43.8 percent rate of protection was no home run but within the same ballpark as the protection seen in other recent prevention trials; the vaginal microbicide trial of tenofovir gel in African women ( 39 percent ) and a vaccine trial in Thailand ( 31 percent ) .

Adherence

Digging deeper, the researchers found that adherence was a very important part of the equation. The men who took at least half of their doses had 50.2 percent fewer infections; those who took at least 90 percent of their medication had 72.8 percent fewer infections. Even the best drugs will not work if people don't take them as they should.

Robert Grant, M.D., is a researcher at the Gladstone Institute at the University of California San Francisco and the principle investigator of the study. He said they asked participants to report how often they took their pills, but because people often are "optimistic" in their recall, and sometimes report what they think researchers want to hear, the study also tested for levels of the drug in the blood of those who became infected.

"No drug was detected in 91 percent; the other 9 percent had detectible levels inside blood cells that were very low. The absence of drug in the blood is probably due to people not taking the drug, which could explain all of the infections that did occur" in that group, Grant said.

The association between adherence and the level of protection was similar to what was seen in the microbicides trial. People who most closely used the product as intended had the best results. Cutting corners gave HIV an opportunity that it quickly exploited.

Reactions

"The iPrEx study results are extreme important and provide strong evidence that PrEP [ preexposure prophylaxis ] can reduce HIV acquisition among a segment of society disproportionately affected by HIV/AIDS," said Anthony Fauci, MD, director of the NIH National Institute of Allergy and Infectious Diseases. It provided $27.8 million toward the study.

He emphasized that despite this good news, "correct and consistent use of condoms and a reduction in the number of sex partners still remain the most effective ways to protect yourself from HIV infection."

"This is great news," said Thomas J. Coates, Ph.D., a leading international HIV prevention researcher at the University of California Los Angeles David Geffen School of Medicine. "But if it would have been any lower, I would have been devastated."

University of Pittsburgh HIV prevention researcher Ronald Stall, Ph.D., called the results "very good news for gay men and other populations at high risk of HIV transmission." It also points to the continued need for better behavioral interventions to support adherence.

Money

Gilead Sciences manufactures Truvada and supported the iPrEx study by providing all of the drugs used. The company said it "will be working with the appropriate regulatory agencies to determine if data from this study warrant inclusion in the prescribing information for Truvada."

While doctors can prescribe drugs for "off label" use that the FDA has not approved, and some already prescribe Truvada for prevention, health insurance companies generally only reimburse for the use indicated on the label of the drug.

Adding a prevention indication to the drug label likely will require additional trials in MSM and other populations, particularly with regard to preventing vaginal transmission of HIV. Some of those studies already are underway.

"The big conundrum right now is what does it mean for practice?" Coates said the response was not sufficiently great to signal immediate widespread adoption of this approach as a prevention intervention, particularly given issues of cost.

The retail price of the drug in the United States is about $14,000 a year, while the NIH pharmacy purchases it for about $5,000 a year, Fauci said.

In developing countries, generic versions of Truvada can be purchased for as little as 40 cents a day, according to Grant. However, those are the same places where more than half of the people already infected with HIV, who meet guidelines to begin treatment, cannot do so because of the cost. It is unlikely that public health officials will devote scarce resources to Truvada when a condom will do the same job much more cheaply.

Furthermore, an international survey of more than 5,000 participants, to be released next week by the Global Forum on MSM & HIV, found that more than half of MSM worldwide do not have access to basic HIV prevention and treatment services. Adding PrEP to the mix will be a challenge.

The paper "Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men" is freely available from the New England Journal of Medicine at www.nejm.org/doi/full/10.1056/NEJMoa1011205.


This article shared 3904 times since Wed Dec 1, 2010
facebook twitter google +1 reddit email

  ARTICLES YOU MIGHT LIKE

Gay News

AIDS Foundation Chicago hosts two-day event about unique challenges facing elders living with HIV/AIDS 2022-09-24
- AIDS Foundation Chicago hosted a two-part educational webinar about the complex needs of elders living with HIV/AIDS Sept. 22-23, where experts discussed how to better serve patients through healthcare, policies ...


Gay News

National AIDS Memorial releases 'The Black Community & AIDS' 2022-09-23
- The National AIDS Memorial has released its latest mini-documentary, "The Black Community & AIDS," the seventh film in its oral history project. "The Black Community & AIDS" chronicles the personal stories of nearly two dozen survivors ...


Gay News

DoJ secures agreement resolving HIV-discrimination suit in Indiana 2022-09-19
- The Justice Department filed a proposed consent decree with the U.S. District Court for the Southern District of Indiana to resolve its lawsuit against the town of Clarksville, Indiana, for violating Title I of the Americans ...


Gay News

AIDS organization honors actors Farrell, Ralph and Theron 2022-09-19
- On Sept. 15, The Elizabeth Taylor AIDS Foundation (ETAF) honored actors Sheryl Lee Ralph, Charlize Theron and Colin Farrell with the Elizabeth Taylor Commitment to End AIDS Award at The Elizabeth Taylor Ball to End AIDS ...


Gay News

Illinois HIV Care Connect introduces its HIV and Aging Campaign 2022-09-15
- In advance of National HIV/AIDS and Aging Awareness Day on Sept. 18, Illinois HIV Care Connect has introduced its HIV and Aging Campaign. Persons aged 50 and older make up nearly half of persons living with ...


Gay News

Texas judge: Mandated PrEP coverage violates religious freedom 2022-09-08
- On Sept. 7, a federal judge in Texas (U.S. District Judge Reed O'Connor) ruled that the government cannot force a Christian-owned company to cover HIV preventative medication (HIV PrEP) because it violates their religious freedom under ...


Gay News

Getting to Zero, AFC award $200K to help end the HIV epidemic in Illinois 2022-09-07
- Getting to Zero Illinois (GTZ-IL) and AIDS Foundation Chicago (AFC) recently awarded $200,000 to community-based organizations implementing strategies to end the HIV/AIDS epidemic by 2030. According to a press release ...


Gay News

Philadelphia AIDS and housing activist Michael Hinson Jr. dies at 55 2022-09-04
- Michael Hinson Jr.—a longtime AIDS and housing activist, and leader in Philadelphia's Black LGBTQ+ community—died Aug. 27 of an undisclosed cause at age 55, The Philadelphia Inquirer reported. An obituary in the Philadelphia Gay News stated ...


Gay News

Howard Brown president/CEO reflects on COVID's impact 2022-08-31
- According to Howard Brown Health President and CEO David Munar, the early days of the COVID-19 pandemic seemed eerily similar to the AIDS crisis of the '80s. "We saw all the same patterns at the dawning ...


Gay News

NATIONAL Gay judge, brewery threatened, Victory Fund, AIDS Quilt 2022-08-28
- New York's highest court has designated Associate Judge Anthony Cannataro to serve as acting chief judge after Janet DiFiore steps down, Gay City News reported. Cannataro, the former administrative judge of New York City's civil court, ...


Gay News

HHS Secretary Becerra announces more than $20 million in funding to end HIV epidemic 2022-08-23
-- From a press release - Today, at the National Ryan White Conference on HIV Care and Treatment, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra announced more than $20 million in funding to expand HIV prevention, testing, and ...


Gay News

Kinsey Institute exhibiting iconic Tom Fox HIV/AIDS photo series 2022-08-05
- An exhibition of 60 iconic photographs documenting Indiana University alumnus Tom Fox's battle with AIDS in the late 1980s will hang in the Grand Hall of Maxwell Hall on the Indiana University-Bloomington campus. "Wild Horse Running: ...


Gay News

Black AIDS Institute seeks president/CEO 2022-07-27
- The Black AIDS Institute (BAI) has partnered with Coleman Lew Canny Bowen, a retained executive search firm, to conduct a search for a president/CEO. This position reports directly to the board of directors and leads a ...


Gay News

Registration for the 31st Annual AIDS Run & Walk only $24 for 24 hours on July 24 2022-07-23
-- From a press release - (Chicago, IL) AIDS Foundation Chicago (AFC) announces the return of its popular $24 for 24 promotion on July 24 for discounted registration for the 31st annual AIDS Run & Walk Chicago (ARWC) taking place Oct. 2 ...


Gay News

Fifteen organizations receive funding from Illinois African American HIV/AIDS Response Act 2022-07-22
-- From a press release - CHICAGO, IL — JULY 22, 2022 — Thirteen African American-led community-based organizations (of 15 possible as the maximum) in Illinois have been awarded grants ranging up to $500,000+ from the ...


 



Copyright © 2022 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 
 

TRENDINGBREAKINGPHOTOS







Sponsor


 

Sponsor


Donate


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots
Identity      BLACKlines      En La Vida      Archives      Advanced Search     
Windy City Queercast      Queercast Archives     
Press  Releases      Join WCMG  Email List      Email Blast      Blogs     
Upcoming Events      Todays Events      Ongoing Events      Bar Guide      Community Groups      In Memoriam     
Privacy Policy     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.